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E-mail: menichettifrancesco@gmail.comFIG. 1. Minimum inhibitory concentrations of colistin on Mueller-
Hinton agar alone (left) and supplemented with rifampin 32 mg/L
(right) against Klebsiella pneumoniae carbapenemase (KPC)-producingThe renewed interest in testing synergistic interactions of
antimicrobial agents is mainly related to the challenge of anti-
microbial resistance. Whereas time-kill curves and checker-
board methods represent the reference tests for screening
synergy, the E-test with strips in a cross formation might be an
interesting alternative, but requires that minimum inhibitory
concentrations (MICs) of antibiotics have been previously
determined [1]. However, agreement between the different
tests seems to be quite variable [1]. To be clinically useful, a
synergy test should be rapid and easily interpretable.
We evaluated the synergistic activity of colistin (COL) plus
rifampin (RIF) against 10 clinical isolates of COL-resistant Klebsi-
ella pneumoniae carbapenemase (KPC)-producing K. pneumoniae
(KPC-Kp) comparing the checkerboard method with the E-test
on Mueller-Hinton agar, alone or supplemented with RIF. The 10
tested strains resulted in KPC3 production by polymerase chain
reaction and Sequence Type (ST) 512 by multilocus sequence
typing (MLST) analysis (http://www.pasteur.fr/recherche/
genopole/PF8/mlst/Kpneumoniae.html). COL MICs for the
checkerboardmethodwere determinedwith brothmicrodilution
in Mueller-Hinton broth alone and supplemented with RIF at the
ﬁnal concentration of 2, 4, 8, 16 and 32mg/L in 96-well microtiter
plates. COL MICs also were determined with the E-test method
on Mueller-Hinton agar alone or supplemented with RIF at the
ﬁnal concentration of 2, 4, 8, 16 and 32mg/L in Petri dishes (Fig. 1).
According to the 2014 EUCAST Clinical Breakpoints, COL
resistance was deﬁned by MIC > 2 mg/L. With the checker-
board method, COL MICs for the 10 strains were 64 mg/LClinical Microbiology and Infection © 2014 European Society of C(5 strains) and 32 mg/L (5 strains). COL MICs decreased below
the susceptibility breakpoint for 8 of 10 strains in the presence
of RIF concentrations of 16 (1 strain), 8 (6 strains) and 2 mg/L
(1 strain). With the E-test method, COL MICs for the 10 strains
were 12 mg/L (1 strain), 8 mg/L (2 strains), 6 mg/L (4 strains)
and 4 mg/L (3 strains). COL MICs for 10 of 10 strains decreased
below the susceptibility breakpoint in the presence of any
concentration of RIF. These results are summarized in Table 1.
RIF MICs results were higher than 32 mg/L with both
methods for all strains. Both methods showed similar results
and were able to show that RIF decreased MICs of COL below
the susceptibility breakpoint in the majority of COL-resistant
KPC-Kp tested strains.
The mechanism of the synergistic activity between COL and
RIF might be related to the perturbation of the outer cellular
membrane produced by COL that favours the penetration of
RIF at intracellular concentrations able to inhibit protein syn-
thesis [2]. The higher COL MICs values observed in our
experiment with the microdilution method with respect to the
E-test already have been reported and seem to be related to the
adsorption of colistin to the microplate plastic wells [3,4].
Although higher COL MICs were observed with the micro-
dilution method, the effect of adding RIF was always evident
also with the lower concentrations.
RIF concentrations showing synergistic activity in vitro were
close to the levels reported after an oral dose of 600 mg [5]. RIF
concentrations higher than 16 mg/L did not induce a further
reductionofCOLMIC, suggesting that higher-than-standard doses
of RIF would probably not offer any signiﬁcant clinical advantage.
The E-test on supplemented agar does not offer information
on the Fractional Inhinitory Concentration Index (sigma FICK. pneumoniae (KPC-Kp).
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TABLE 1. Minimum inhibitory concentration (MIC) of colistin alone and in the presence of rifampin (RIF) 2, 4, 8, 16 and 32 mg/L
against Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae
Strain Method
Colistin MIC (mg/L)
Alone +RIF 2 mg/L +RIF 4 mg/L +RIF 8 mg/L +RIF 16 mg/L +RIF 32 mg/L
8252/10 E-test 6 1 1 1 0.5 0.5
Checkerboard 32 4 4 2 2 2
8546/10 E-test 8 1 1 0.75 0.75 0.5
Checkerboard 32 8 4 2 2 2
9761/10 E-test 12 1.5 1.5 0.75 0.75 0.75
Checkerboard 64 2 2 2 2 2
4680/11 E-test 6 1.5 1.5 0.75 0.5 0.5
Checkerboard 32 4 4 4 4 4
12 613/10 E-test 4 1.5 1 0.75 0.5 0.38
Checkerboard 32 4 4 2 2 2
2018/12 E-test 6 1.5 1.5 0.75 0.75 0.38
Checkerboard 64 16 16 2 2 2
2550/12 E-test 4 1 1 0.75 0.75 0.5
Checkerboard 128 16 16 2 2 2
2762/12 E-test 6 1 1 1 0.75 0.5
Checkerboard 64 8 4 4 2 2
3031/12 E-test 4 1.5 1.5 1 0.75 0.5
Checkerboard 32 16 16 16 4 4
3342/12 E-test 8 1 1 1 1 0.5
Checkerboard 64 8 4 2 2 2
Shading indicates values below the clinical breakpoint of colistin (2 mg/L).
e8 Clinical Microbiology and Infection, Volume 21 Number 2, February 2015 CMIindex) nor on bactericidal activity. However, in clinical practice,
the reduction of the MIC of agent A in presence of agent B, the
extent of such a reduction, and the concentration of agent B
needed might be more useful. In our experience, E-test on
supplemented media is easy to perform, and the agreement with
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